The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer.
about
Estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer.Estrogen receptors as the novel therapeutic biomarker in non-small cell lung cancer.SNAI2/SLUG and estrogen receptor mRNA expression are inversely correlated and prognostic of patient outcome in metastatic non-small cell lung cancerDifferential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms.Estrogen receptor alpha promotes smoking-carcinogen-induced lung carcinogenesis via cytochrome P450 1B1.Estrogen and cigarette sidestream smoke particulate matter exhibit ERα-dependent tumor-promoting effects in lung adenocarcinoma cells.
P2860
The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
The validation of estrogen rec ...... ic non-small cell lung cancer.
@en
The validation of estrogen rec ...... ic non-small cell lung cancer.
@nl
type
label
The validation of estrogen rec ...... ic non-small cell lung cancer.
@en
The validation of estrogen rec ...... ic non-small cell lung cancer.
@nl
prefLabel
The validation of estrogen rec ...... ic non-small cell lung cancer.
@en
The validation of estrogen rec ...... ic non-small cell lung cancer.
@nl
P2093
P2860
P356
P1476
The validation of estrogen rec ...... ic non-small cell lung cancer.
@en
P2093
Akin Atmaca
Arndt Hartmann
Corinna Eschbach
Dominique Werner
Elke Jäger
Gunther Wiest
Ralph Markus Wirtz
Sabine Zirlik
Salah-Eddin Al-Batran
Silke Claas
P2860
P304
P356
10.1002/IJC.28571
P577
2013-11-14T00:00:00Z